MEMS, wearable/implantable electronics and bio-tissue therapeutics, the pursuit of piezoelectric biomaterials has become a ...

Analysts estimate that Bio-Path Holdings will report an earnings per share (EPS) of $-1.02. Anticipation surrounds Bio-Path ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...

Ariel Investments, an investment management company, released its “Ariel Focus Fund” third-quarter 2024 investor letter. A ...

The primary contractor for the project will be appointed next week. Keturah completes infrastructure work on Dubai’s first ...

Shares of Avidity Biosciences surged to a record high Wednesday after the company showed its hand in the cardiovascular space ...

PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection. FDA 510(k) Clearance ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported third quarter results and business highlights for the quarter ended September ...

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of ...

Binance Labs has invested in BIO Protocol, marking its first venture into decentralized science. BIO Protocol’s BioDAO ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...